Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I'm not sure I understand slide 6 from today's power point. No key is provided and the scaling is not completely clear.
What is the takeaway?
Thanks in advance